Article
Permanent neonatal diabetes by a new mutation in KCNJ11: unsuccessful switch to sulfonylurea.
Archives of endocrinology and metabolism - 1 Dec 2015
Lau Eva, Correia Cintia, Freitas Paula, Nogueira Claúdia, Costa Maria, Saavedra Ana, Costa Carla, Carvalho Davide, Fontoura Manuel
Abstract excerpt
Permanent neonatal diabetes (PNDM) can result from activating heterozygous mutations in KCNJ11 gene, encoding the Kir6.2 subunit of the pancreatic ATP-sensitive potassium channels (KATP). Sulfonylureas promote KATP closure and stimulate insulin secretion, being an alternative therapy in PNDM, instead of insulin. Male, 20 years old, diagnosed with diabetes at 3 months of age. The genetic study identified a novel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
